Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
5-Aminosalicylic acid (5-ASA) enemas constitute a first-line therapy for patients with mild to moderate attacks of ulcerative colitis. To date, based on the results of different studies, 5-ASA enemas appear to be satisfactory in at least two-thirds of patients treated. Beclomethasone is one of the n...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1990/164896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | 5-Aminosalicylic acid (5-ASA) enemas constitute a first-line
therapy for patients with mild to moderate attacks of ulcerative colitis. To date,
based on the results of different studies, 5-ASA enemas appear to be satisfactory
in at least two-thirds of patients treated. Beclomethasone is one of the new
corticosteroids which appear to have minimal systemic effects. The authors have
assessed the efficacy of a four week course of 3 mg beclomethasone enemas
compared to 2 g 5-ASA enemas in patients with ulcerative colitis. Preliminary
analysis would suggest that both therapies are effective in more than 50% of cases. |
|---|---|
| ISSN: | 0835-7900 |